Highlight
• Cisplatin treatment commonly results in decreased kidney function, with approximately 13.6% of patients developing chronic kidney disease (CKD) post-treatment.
• A simple predictive model based on baseline estimated glomerular filtration rate (eGFR) alone robustly forecasts post-cisplatin CKD risk and kidney function decline.
